Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Zippia finds jobs where you're a top candidate and applies on your behalf.
Alere's peak revenue was $2.6B in 2013. The peak quarterly revenue was $764.0M in 2013(q2).
Alere's revenue increased from $49.7m in 2000 to $2.4B currently. That's a 4,678.71% change in annual revenue.
| Fiscal year / year | Alere revenue |
|---|---|
| 2009 | $1.9B |
| 2010 | $2.2B |
| 2011 | $2.4B |
| 2012 | $2.4B |
| 2013 | $2.6B |
| 2014 | $2.6B |
| 2015 | $2.5B |
| 2016 | $2.4B |
How accurately did Alere's revenue projections match actual performance?
Alere saw the greatest revenue growth in 2002, when revenue increased by 337.51%.
Alere had the lowest revenue growth in 2001, when revenue changed by -4.95%.
| Year | Alere growth |
|---|---|
| 2009 | 21%↑ |
| 2010 | 12%↑ |
| 2011 | 11%↑ |
| 2012 | 0%↑ |
| 2013 | 9%↑ |
| 2014 | -1%↓ |
| 2015 | -5%↓ |
| 2016 | -3%↓ |
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2009 | $425.2M | $438.7M | $512.7M | $546.2M |
| 2010 | $515.3M | $523.0M | $538.7M | $578.5M |
| 2011 | $582.5M | $567.2M | $585.8M | $651.1M |
| 2012 | $671.1M | $700.5M | $691.4M | $331.3M |
| 2013 | $739.2M | $764.0M | $650.6M | $664.2M |
| 2014 | $625.2M | $647.4M | $649.2M | $655.2M |
| 2015 | $612.9M | $623.4M | $603.8M | $615.6M |
| 2016 | $586.9M | $610.3M | $582.4M | $604.7M |
| 2017 | $588.2M | $557.7M | - | - |
Do you work at Alere?
Did Alere meet its revenue projections?
| CEO | Michael Cotton (Mike) |
| Company Type | Public |
| Employees Number | 9,700 |
| Date Founded | 1981 |
| Headquarters | Waltham, Massachusetts |
| Number of Locations | 27 |
| Revenue | $2.4B |
| Net Income | -$137,619,000 |
| Gross Proft | $1.1B (2016) |
| Tax Rate | -0.2% |
| Total Assets | $5,648,279,000 |
| Ticker | ALR |
Alere received early financing of $6.4M on 2003-03-30.
| Series | Round size | Date |
|---|---|---|
| Debt Financing | $6.4M | 03/2003 |
| Series Unknown | $5.1M | 03/2003 |
| Debt Financing | $100M | 10/2009 |
| Post Ipo Debt | $400M | 09/2010 |
| Investors | Security type |
|---|---|
| Western Technology Investment | Debt Financing |
| SR One | Series Unknown |
| Institutional Venture Partners (IVP) | Series Unknown |
| Cutlass Capital LLC | Series Unknown |
Alere's top competitor, Medtronic, earned an annual revenue of $17.0B.
Alere's smallest competitor is Prolacta Bioscience with revenue of $3.2M last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Medtronic | $73,671 | $17.0B | 104,950 | 1,938 |
| Genentech | $97,473 | $166.9M | 13,638 | 512 |
| MicroPort | $73,160 | $444.2M | 5,000 | 12 |
| Hologic | $72,888 | $4.0B | 6,478 | 486 |
| Bio-Rad Laboratories | $93,296 | $2.8B | 8,250 | 69 |
| Alcon | $60,684 | $9.9B | 20,001 | 239 |
| Immucor | $60,486 | $380.0M | 1,125 | - |
| IDEXX | $59,931 | $3.9B | 9,300 | 226 |
| Mtf | $44,385 | $3.6M | 50 | - |
| HealthTronics | $56,538 | $21.4M | 658 | 17 |
Zippia gives an in-depth look into the details of Alere, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Alere. The employee data is based on information from people who have self-reported their past or current employments at Alere. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Alere. The data presented on this page does not represent the view of Alere and its employees or that of Zippia.
Alere may also be known as or be related to ALERE INC., Abbott, Alere, Alere Inc, Alere Inc., Alere, Inc. and Inverness Medical Innovations, Inc.